These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15503426

  • 1. Etiology of increased enzymuria in different morphological forms of glomerulonephritis.
    Kuźniar J, Marchewka Z, Lembas-Bogaczyk J, Kuźniar TJ, Klinger M.
    Nephron Physiol; 2004; 98(1):p8-14. PubMed ID: 15503426
    [Abstract] [Full Text] [Related]

  • 2. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G.
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [Abstract] [Full Text] [Related]

  • 3. Elastase deposits in the kidney and urinary elastase excretion in patients with glomerulonephritis--evidence for neutrophil involvement in renal injury.
    Kuźniar J, Kuźniar TJ, Marchewka Z, Lembas-Bogaczyk J, Rabczyński J, Kopeć W, Klinger M.
    Scand J Urol Nephrol; 2007 Nov; 41(6):527-34. PubMed ID: 17853021
    [Abstract] [Full Text] [Related]

  • 4. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I, Krzymański M.
    Przegl Lek; 1996 Nov; 53(5):443-53. PubMed ID: 8754411
    [Abstract] [Full Text] [Related]

  • 5. Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-β-D-glucosaminidase in glomerulonephritis.
    Bazzi C, Rizza V, Olivieri G, Casellato D, D'Amico G.
    J Nephrol; 2015 Oct; 28(5):541-8. PubMed ID: 25227764
    [Abstract] [Full Text] [Related]

  • 6. Enzymuria and beta2-mikroglobulinuria in the assessment of the influence of proteinuria on the progression of glomerulopathies.
    Marchewka Z, Kuźniar J, Długosz A.
    Int Urol Nephrol; 2001 Oct; 33(4):673-6. PubMed ID: 12452627
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of N-acetyl-beta-D-glucosaminidase in proteinuric states.
    Ring E, Zobel G, Erwa W, Haim-Kuttnig M.
    Child Nephrol Urol; 1992 Oct; 12(1):15-8. PubMed ID: 1606575
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Different erythrocyte and platelet surface electric charge in various types of glomerulonephritis.
    Klinger M, Kramarz S, Wendycz D, Kopec W.
    Nephrol Dial Transplant; 1997 Apr; 12(4):707-12. PubMed ID: 9140998
    [Abstract] [Full Text] [Related]

  • 11. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
    Hultberg B, Ravnskov U.
    Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
    [Abstract] [Full Text] [Related]

  • 12. Local macrophage proliferation in human glomerulonephritis.
    Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, Lan HY.
    Kidney Int; 1998 Jul; 54(1):143-51. PubMed ID: 9648072
    [Abstract] [Full Text] [Related]

  • 13. Urinary enzymatic markers (N-acetyl-beta-D-glucosaminidase) in assessing the tubulointerstitial compartment in chronic glomerulonephritis related to odontogenic foci.
    Velciov S, Gluhovschi G, Timar R, Gluhovschi C, Petrica L, Bob F, Bozdog G, Pricop M, Gluhovschi A, Cornianu M, Potencz E, Timar B, Kaycsa A.
    Wien Klin Wochenschr; 2016 Feb; 128(3-4):102-8. PubMed ID: 26377174
    [Abstract] [Full Text] [Related]

  • 14. Kidney Biopsy: An Experience from Tertiary Hospital.
    Ghimire M, Pahari B, Paudel N, Das G, Das GC, Sharma SK.
    JNMA J Nepal Med Assoc; 2014 Feb; 52(193):707-12. PubMed ID: 26905553
    [Abstract] [Full Text] [Related]

  • 15. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.
    Erdener D, Aksu K, Biçer I, Doğanavşargil E, Kutay FZ.
    J Clin Lab Anal; 2005 Feb; 19(4):172-6. PubMed ID: 16025478
    [Abstract] [Full Text] [Related]

  • 16. The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.
    Gluhovschi C, Velciov S, Kaycsa A, Gluhovschi G, Petrica L, Marian R, Bozdog G, Gadalean F, Bob F, Cioca D, Vernic C.
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):163-9. PubMed ID: 21651460
    [Abstract] [Full Text] [Related]

  • 17. [Clinical investigation of urinary activity of NAG and AAP in patients with various types of primary glomerulonephritis].
    Soezima A, Suzuki M, Fukutomi K, Nakabayasi K, Kitamoto K, Nagasawa T.
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):321-6. PubMed ID: 2568510
    [Abstract] [Full Text] [Related]

  • 18. [Enzymuria and kidney diseases in childhood].
    Ehrich JH, Wurster U, Lütge M, Doehring E, Oemar B.
    Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198
    [Abstract] [Full Text] [Related]

  • 19. Urinary N-acetyl-beta-D-glucosaminidase and beta 2-microglobulin excretion in primary nephrotic children.
    Calişkan S, Hacibekiroğlu M, Sever L, Ozbay G, Arisoy N.
    Nephron; 1996 Dec; 74(2):401-4. PubMed ID: 8893163
    [Abstract] [Full Text] [Related]

  • 20. Uric acid excretion and dopamine-induced glomerular filtration response in patients with IgA glomerulonephritis.
    Sulikowska B, Manitius J, Odrowaz-Sypniewska G, Łysiak-Szydłowska W, Rutkowski B.
    Am J Nephrol; 2008 Dec; 28(3):391-6. PubMed ID: 18063857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.